Posted on May 29, 20265/29/26
The Indispensable Edge: Why the EVERSANA AI Agency Platform is a Must-Have for Expert Oncology Marketers
Posted on May 28, 20265/28/26
Bridging Evidence Gaps in mCRPC: Highlighting the Potential of Talazoparib plus Enzalutamide
Posted on May 26, 20265/26/26
Decoding the Dialogue: Transforming MSL Interactions into Congress Intelligence
Posted on May 21, 20265/21/26
The Shattered Glass: Why the Future of Oncology Patient Support is an Agentic Ecosystem, Not a Portal
Posted on January 14, 20261/14/26
The Combination Crossfire: Is Your Brand Strategy Strong Enough to Align Payers, Prescribers, and Patients?
Posted on January 5, 20261/5/26
A New Marketing Mandate in Community Oncology
Posted on December 17, 202512/17/25
The Enablement Helix: An Evolving Framework for Market Success in Oncology
Posted on November 30, 202511/30/25
The Oncologist’s Next Ally: Why Cancer Is Forging the Future of Clinical AI
Posted on October 31, 202510/31/25
AI in Oncology: Acceleration, Accessibility, and Accuracy
Posted on October 30, 202510/30/25